Showing 6981-6990 of 8649 results for "".
- LKC Technologies: RETeval DR Score Superior in Predicting Diabetic Retinopathy Outcomeshttps://modernod.com/news/lkc-technologies-reteval-dr-score-superior-in-predicting-diabetic-retinopathy-outcomes/2482924/LKC Technologies, a provider of electroretinography (ERG)-based functional diagnostics, announced the publication of a study that found that ERG/pupillometry outperforms structural imaging in identifying patients at highest risk of progressing to vision-t
- 4DMT Provides New 60-Week Results for Gene Therapy Candidate for DMEhttps://modernod.com/news/4dmt-provides-new-60-week-results-for-gene-therapy-candidate-for-dme/2482922/4D Molecular Therapeutics (4DMT) announced interim results from its SPECTRA phase 2a clinical trial evaluating 4D-150 for diabetic macular edema (DME). The data were presented at the 43rd Annual American Society of Retina Specialists (ASRS) scientific mee
- Kowa Initiates Phase 3 Safety Trial for Glaucoma Drug Candidate NCX 470 in Japanhttps://modernod.com/news/kowa-initiates-phase-3-safety-trial-for-glaucoma-drug-candidate-ncx-470-in-japan/2482918/Nicox announced that its exclusive Japanese partner, Kowa, has officially initiated a phase 3 safety clinical trial for NCX 470 (also referred to as K-911) in Japan. NCX 470 is Nicox’s lead clinical candidate, currently undergoing phase 3 clinical evaluations
- Reciprocal Tariffs Take Effect: What Eye Care Professionals Need to Knowhttps://modernod.com/news/reciprocal-tariffs-take-effect-august-7-what-eye-care-professionals-need-to-know/2482916/Eye care professionals and optical businesses across the US are bracing for major changes as the White House prepares to implement new reciprocal tariffs on imported goods from key trade partners beginning August 7, 2025. The tarriffs come following a temp
- Kate Flannery Teams Up with Contact Lens Institute to Promote 'The EASY Way' for Contact Lens Healthhttps://modernod.com/news/kate-flannery-teams-up-with-contact-lens-institute-to-promote-the-easy-way-for-contact-lens-health/2482914/Comedian Kate Flannery has partnered with the Contact Lens Institute (CLI) to amplify a new campaign titled 'The EASY Way,' with the goal of communicating safe, effective soft contact lens wear-and-care routines.
- Viridian Therapeutics Enters Collaboration to Develop and Commercialize Thyroid Eye Disease Therapies in Japanhttps://modernod.com/news/viridian-therapeutics-enters-collaboration-to-develop-and-commercialize-thyroid-eye-disease-therapies-in-japan/2482910/Viridian Therapeutics announced an exclusive collaboration and license agreement with Kissei Pharmaceutical to develop and commercialize investigatonal drug candidates veligrotug and VRDN-003 in Japan. Both veligrotug and
- The Vision Council Releases Updated Version of Data Communication Standardhttps://modernod.com/news/the-vision-council-releases-updated-version-of-data-communication-standard/2482899/The Vision Council announced the official release and approval of Version 3.14 of its Data Communication Standard in an effort to advance the efficiency, accuracy, and interoperability of optical manufacturing systems.
- Julia Haller, MD, Named CEO of Wills Eye Hospitalhttps://modernod.com/news/julia-haller-md-named-ceo-of-wills-eye-hospital/2482897/Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital, will also become the hospital's next Chief Executive Officer. Dr. Haller assumed the expanded leadership post on July 18, succeeding longtime CEO Joseph P. Bilson, who reti
- Viatris Fails Phase 3 Study of MR-139 for Blepharitishttps://modernod.com/news/viatris-fails-phase-3-study-of-mr-139-for-blepharitis/2482893/Viatris announced that its phase 3 study evaluating the efficacy and safety of pimecrolimus 0.3% (MR-139) for blepharitis did not meet its primary endpoint of complete resolution of debris after six weeks of twice daily dosing. The MR-139 3001 phase 3 trial cons
- Stuart Therapeutics Publishes New Study Demonstrating Potential of Collagen Mimetic Peptides in Treating Ophthalmic Diseasehttps://modernod.com/news/stuart-therapeutics-publishes-new-study-demonstrating-potential-of-collagen-mimetic-peptides-in-treating-ophthalmic-disease/2482887/Stuart Therapeutics announced the publication of a preclinical study in Pharmaceuticals highlighting the potential of collagen mimetic peptides (CMPs) in restor